TrialAmerican journal of hematology2020

Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403.

Lawrence D Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.